Denmark· DK-28106410620

3013

A fluticasonpropionat, salmeterolxinafoat product, registered in Denmark by 12,75+202 mikrogram.

ATC FLUTICASONPROPIONAT, SALMETEROLXINAFOAT

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalised3013ATCFLUTICASONPROPIONAT, …REGISTER NO.DK-28106410620PACKS LISTED1CHECKEDSeptember 16, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Manufacturer
12,75+202 mikrogram
Country
Denmark (DK)
ATC code
FLUTICASONPROPIONAT, SALMETEROLXINAFOAT
ATC class
FLUTICASONPROPIONAT, SALMETEROLXINAFOAT
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 16, 2026

Packs & prices · 1

  • dk_varenummer
    28106410620

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under FLUTICASONPROPIONAT, SALMETEROLXINAFOAT

Fluticasonpropionat, salmeterolxinafoat, as other registers publish it.

All 3013 products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba650f37-329e-43ed-93fd-c202540d937b
GET /v1/drugs/ba650f37-329e-43ed-93fd-c202540d937b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": null,
  "source": "dkma",
  "strength": "680",
  "auth_role": "R03AK06",
  "dk_drugid": "28106410620",
  "substance": null,
  "auth_procedure": "Teva B.V.",
  "in_medicinpriser": false,
  "registration_date_serial": "Central"
}

See everything about 3013.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.